Receives Positive Interim Results of Lifecycle Testing
Enactment of Federal ‘NOPAIN Act' Could Be a Catalyst
NanoVibronix, Inc. (NASDAQ:NAOV) (the "Company"), a medical device company utilizing
The Dow Jones closed lower by more than 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.